Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions Announces 300% Increase in Utilization of Aquadex Therapy in NYC Hospitals, the Epicenter of COVID-19
EDEN PRAIRIE, Minn. , April 16, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced increased utilization of its Aquadex therapy in patients affected by COVID-19.
View HTML
Toggle Summary CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management When Access to Dialysis Machines is Limited or Not Available
Citing Risk of Acute Kidney Injury, April 10th Physician-led Webinar Presented Real World Case Studies on Patients with COVID-19 EDEN PRAIRIE, Minn. , April 14, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from
View HTML
Toggle Summary CHF Solutions Submits Patent Application for Hemofiltration System for Rapid Clearing of Cytokines in COVID-19 patients
EDEN PRAIRIE, Minn. , April 09, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for an adaptation to the Aquadex SmartFlow™ system to
View HTML
Toggle Summary CHF Solutions Convenes Physicians to Discuss Cardio-Pulmonary-Renal Management of COVID-19 Patients
EDEN PRAIRIE, Minn. , April 08, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, clinician-led webinar to discuss cardio-pulmonary-renal
View HTML
Toggle Summary CHF Solutions Doubles Production Staff of Aquadex SmartFlow™ Consoles Due to Hospital Demand
EDEN PRAIRIE, Minn. , April 02, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that it has doubled the production staff that builds its next generation Aquadex SmartFlow consoles in
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
EDEN PRAIRIE, Minn. , March 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 5,130,228 shares of its common stock at a price to the public of $0.434 per share, for gross proceeds of approximately $2,226,000 , prior to deduction
View HTML
Toggle Summary CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management
Company increases production in response to expected demand EDEN PRAIRIE, Minn. , March 25, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced the use of its Aquadex therapy in the
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
EDEN PRAIRIE, Minn. , March 20, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 4,161,392 shares of its common stock at a price to the public of $0.30 per share, for gross proceeds of approximately $1,248,000 , prior to deduction
View HTML
Toggle Summary CHF Solutions’ Aquadex FlexFlow® System is licensed and approved for sale in India
EDEN PRAIRIE, Minn. , March 19, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the Aquadex FlexFlow system has been licensed and approved for sale in India , making ultrafiltration therapy available for patients suffering from hypervolemia, or fluid overload, in one of the
View HTML
Toggle Summary CHF Solutions Webinar Highlighted Importance of Fluid Management in Patients Treated for COVID-19
Proper Control of Fluids Routinely Administered to Patients with Acute Respiratory Infections Play Important Role in Successful Outcomes EDEN PRAIRIE, Minn. , March 18, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients
View HTML